Position in RPRX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$12,334,839
+$3,498,190 QoQ
Shares Held
219,990
+19.4% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#135
of 641 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tredje AP-fonden holds $108,189,503 across 9 Biotechnology names. RPRX ranks #3 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
48,079 | $29,979,179 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
59,459 | $29,535,069 | |
| 3 | RPRX |
Royalty Pharma plc
This page
|
219,990 | $12,334,839 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
37,206 | $11,200,122 | |
| 5 | INCY |
Incyte Corp
|
67,814 | $7,687,395 | |
| 6 | ASND |
Ascendis Pharma A/S
|
20,448 | $5,453,890 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
27,000 | $5,056,560 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
60,944 | $3,487,215 |
All Filings in RPRX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,334,839 | 219,990 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $8,836,649 | 184,212 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,065,848 | 53,464 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,302,502 | 36,919 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,755,033 | 76,465 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,593,077 | 51,175 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,305,474 | 51,175 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,895,481 | 102,350 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $2,698,969 | 102,350 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,741,310 | 123,191 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,045,124 | 108,406 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,942,138 | 108,406 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,444,509 | 112,053 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $4,289,047 | 119,041 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,793,905 | 70,696 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,761,370 | 68,725 | Shares | Sole | 2022-11-10 | |
| No filing history on record for this holder in this stock. | ||||||